相似文献
1
Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs.
Cancer Lett. 2010 Jun 1;292(1):48-53. doi: 10.1016/j.canlet.2009.11.006. Epub 2009 Dec 3.
2
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Cancer Res. 2007 May 1;67(9):4303-10. doi: 10.1158/0008-5472.CAN-06-4699.
3
Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Cancer Lett. 2007 Jan 8;245(1-2):232-41. doi: 10.1016/j.canlet.2006.01.027. Epub 2006 Mar 6.
4
Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Lasers Surg Med. 2011 Sep;43(7):644-50. doi: 10.1002/lsm.21081.
5
Green tea polyphenols as a natural tumour cell proteasome inhibitor.
Inflammopharmacology. 2008 Oct;16(5):208-12. doi: 10.1007/s10787-008-8017-8.
6
Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
Nanomedicine. 2014 Nov;10(8):1619-26. doi: 10.1016/j.nano.2014.05.007. Epub 2014 Jun 3.
7
Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Int J Pharm. 2020 Jul 30;585:119449. doi: 10.1016/j.ijpharm.2020.119449. Epub 2020 May 25.
8
Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
Cancer Biol Ther. 2007 Dec;6(12):1938-43. doi: 10.4161/cbt.6.12.4974. Epub 2007 Sep 1.
9
Synthetic peracetate tea polyphenols as potent proteasome inhibitors and apoptosis inducers in human cancer cells.
Front Biosci. 2005 May 1;10:1010-23. doi: 10.2741/1595.
10
Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Clin Cancer Res. 2004 Jul 15;10(14):4865-73. doi: 10.1158/1078-0432.CCR-03-0672.
引用本文的文献
1
Epigallocatechin-3-Gallate, an Active Green Tea Component to Support Anti-VEGFA Therapy in Wet Age-Related Macular Degeneration.
Nutrients. 2023 Jul 28;15(15):3358. doi: 10.3390/nu15153358.
2
Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.
RSC Chem Biol. 2020 Dec 1;1(5):305-332. doi: 10.1039/d0cb00111b. Epub 2020 Sep 16.
3
Preclinical Pharmacological Activities of Epigallocatechin-3-gallate in Signaling Pathways: An Update on Cancer.
Molecules. 2020 Jan 22;25(3):467. doi: 10.3390/molecules25030467.
4
Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge.
Infect Agent Cancer. 2020 Jan 10;15:2. doi: 10.1186/s13027-020-0270-5. eCollection 2020.
5
Cancer Chemoprevention by Phytochemicals: Nature's Healing Touch.
Molecules. 2017 Mar 3;22(3):395. doi: 10.3390/molecules22030395.
6
Broad targeting of angiogenesis for cancer prevention and therapy.
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S224-S243. doi: 10.1016/j.semcancer.2015.01.001. Epub 2015 Jan 16.
7
Molecular targets of naturopathy in cancer research: bridge to modern medicine.
Nutrients. 2015 Jan 6;7(1):321-34. doi: 10.3390/nu7010321.
8
Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells.
Bioorg Med Chem. 2012 May 1;20(9):3031-7. doi: 10.1016/j.bmc.2012.03.002. Epub 2012 Mar 9.
9
Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization.
Anticancer Agents Med Chem. 2012 Oct 1;12(8):891-901. doi: 10.2174/187152012802649978.
10
Recent advances on tea polyphenols.
Front Biosci (Elite Ed). 2012 Jan 1;4(1):111-31. doi: 10.2741/363.
本文引用的文献
1
Clinical development of novel proteasome inhibitors for cancer treatment.
Expert Opin Investig Drugs. 2009 Jul;18(7):957-71. doi: 10.1517/13543780903002074.
2
Prodrugs of fluoro-substituted benzoates of EGC as tumor cellular proteasome inhibitors and apoptosis inducers.
Int J Mol Sci. 2008 Jun;9(6):951-961. doi: 10.3390/ijms9060951. Epub 2008 Jun 2.
3
Multitargeted therapy of cancer by green tea polyphenols.
Cancer Lett. 2008 Oct 8;269(2):269-80. doi: 10.1016/j.canlet.2008.04.014. Epub 2008 May 22.
4
Tea polyphenols, their biological effects and potential molecular targets.
Histol Histopathol. 2008 Apr;23(4):487-96. doi: 10.14670/HH-23.487.
5
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Cancer Res. 2007 May 1;67(9):4303-10. doi: 10.1158/0008-5472.CAN-06-4699.
6
Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.
J Cell Physiol. 2007 Oct;213(1):252-60. doi: 10.1002/jcp.21124.
7
The proteasome as a potential target for novel anticancer drugs and chemosensitizers.
Drug Resist Updat. 2006 Dec;9(6):263-73. doi: 10.1016/j.drup.2006.11.001. Epub 2007 Jan 2.
8
The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".
Mol Pharmacol. 2007 Feb;71(2):426-37. doi: 10.1124/mol.106.030015. Epub 2006 Nov 8.
9
Metabolism of green tea catechins: an overview.
Curr Drug Metab. 2006 Oct;7(7):755-809. doi: 10.2174/138920006778520552.
10
Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
Cancer Res. 2006 May 1;66(9):4758-65. doi: 10.1158/0008-5472.CAN-05-4529.
Zotero 插件